Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
ITI Pharma and Healthcare Fund Reg (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 08-Nov-21
Corpus(Cr.) 276.00 Latest NAV 17.481 As on 29-10-2026
Equity(%) 99.31 52 Week High 18.4454
Debt(%) 0.69 52 Week Low 14.4974
Others(%) 0.00 Exit Load 0.5% for redemption within 3 months
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark NIFTY Healthcare TRI. Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Animesh Singh
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 36.48%
Top 10 Holdings 56.97%
Top 25 Holdings 88.55%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 74.79
Healthcare 22.38
Consumer Durables 1.22
Chemicals 0.92
Cash 0.69
 
 
 
 
 
Portfolio Metrics
PB Ratio 6.12
PE Ratio 48.55
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Ltd. 11.96
Divis Laboratories Ltd. 9.51
Apollo Hospitals Enterprises Ltd. 5.45
Dr. Reddys Laboratories Ltd. 4.78
Torrent Pharmaceuticals Ltd. 4.78
Max Healthcare Institute Limited 4.49
Cipla Ltd. 4.19
Laurus Labs Limited 4.02
Aurobindo Pharma Ltd. 4.01
Mankind Pharma Limited 3.78
Cohance Lifesciences Limited 3.14
Alkem Laboratories Limited 3.09
Neuland Laboratories Limited. 3.07
Global Health Limited 2.85
Fortis Healthcare Ltd 2.77
Abbott India Ltd. 2.14
Lupin Ltd 2.04
Ipca Laboratories Ltd. 1.94
Sai Life Sciences Limited 1.87
Shilpa Medicare Ltd. 1.61
Aster DM Healthcare Limited 1.59
Poly Medicure Ltd 1.48
HealthCare Global Enterprises Limited 1.47
PIRAMAL PHARMA LIMITED 1.27
Anthem Biosciences Limited 1.25

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-3.32% -2.48% 9.78% 6.33%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-2.23% -2.98% 8.71% 8.99%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
2.22% 17.82% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
6.75% 21.05% 14.18% 10.60%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
ITI Pharma and Healthcare Fund Reg (G) 16.74% 0.9643 11.1207% 43.1081 0.1341
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
ITI Pharma and Healthcare Fund Reg (G) 15.2994% 0.0000 202.2483 19.6204 1.7848
 
Back to Selection